The Ministry of Health of the Russian Federation in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On the circulation of medicinal products" decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate P N014598 / 01 from 17.03.2009 issued by Johnson & Johnson, Russia):
Reminil® (trade name of the drug)
Galantamine (international non-proprietary or grouping or chemical name)
film coated tablets, 4 mg, 8 mg, 12 mg (dosage form, dosage)
Janssen-Szilag SpA, Italy Via FROM. Janssen, 04010 Borgo San Michele, Latina, Italy (name and address of the location of the manufacturer of the medicinal product)
on the basis of an application by an authorized legal entity LLC Johnson & Johnson to cancel the state registration of the medicinal product.